Michael J Banker

Discovery of two clinical histamine H(3) receptor antagonists: trans-N-ethyl-3-fluoro-3-[3-fluoro-4-(pyrrolidinylmethyl)phenyl]cyclobutanecarboxamide (PF-03654746) and trans-3-fluoro-3-[3-fluoro-4-(pyrrolidin-1-ylmethyl)phenyl]-N-(2-methylpropyl)cyclobutanecarboxamide (PF-03654764).

Jiri Aubrecht, Scot Mente, Jennifer B Munzner, 2011, Journal of medicinal chemistry.

Development and validation of a 96-well equilibrium dialysis apparatus for measuring plasma protein binding.

Michael J Banker, John A. Williams, Tracey H Clark, 2003, Journal of pharmaceutical sciences.

Predicting safety toleration of pharmaceutical chemical leads: cytotoxicity correlations to exploratory toxicity studies.

Jiri Aubrecht, M. Aleo, J. Aubrecht, 2010, Toxicology letters.